APA citiranje

Yoo, C., Kang, J., Kim, K., Lee, J., Ryoo, B., Chang, H., . . . Kim, S. C. (2017). Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: Improved efficacy compared with gemcitabine-based regimen. Oncotarget.

Citação norma Chicago

Yoo, Changhoon, et al. "Efficacy and Safety of Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: Improved Efficacy Compared With Gemcitabine-based Regimen." Oncotarget 2017.

MLA citiranje

Yoo, Changhoon, et al. "Efficacy and Safety of Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: Improved Efficacy Compared With Gemcitabine-based Regimen." Oncotarget 2017.